Jonathan Romanyshyn, MD
Assistant Professor
Surgery - Fresno
School of Medicine

Publications (6)

Top publication keywords:
Glutaminegamma-Aminobutyric AcidDopamine AgonistsNeuroendocrine TumorsRestless Legs SyndromeDrug Resistant EpilepsyGlutamic AcidMicrodialysisHippocampusGastrostomyTumor BurdenPancreatic NeoplasmsOropharyngeal NeoplasmsChemoradiotherapyRadiotherapy, Intensity-Modulated

• Predicting Aggressive Behavior in Nonfunctional Pancreatic Neuroendocrine Tumors With Emphasis on Tumor Size Significance and Survival Trends: A Population-Based Analysis of 1787 Patients.
  The American surgeon 2020 Fathi AH, Romanyshyn J, Barati M, Choudhury U, Chen A, Sosa JA
• Elevated basal glutamate and unchanged glutamine and GABA in refractory epilepsy: Microdialysis study of 79 patients at the yale epilepsy surgery program.
  Annals of neurology 2016 Çavus I, Romanyshyn JC, Kennard JT, Farooque P, Williamson A, Eid T, Spencer SS, Duckrow R, Dziura J, Spencer DD
• Percutaneous endoscopic gastrostomy in oropharyngeal cancer patients treated with intensity-modulated radiotherapy with concurrent chemotherapy.
  Cancer 2012 Romesser PB, Romanyshyn JC, Schupak KD, Setton J, Riaz N, Wolden SL, Gelblum DY, Sherman EJ, Kraus D, Lee NY
• Intensity-modulated radiation therapy in oropharyngeal carcinoma: effect of tumor volume on clinical outcomes.
  International journal of radiation oncology, biology, physics 2011 Lok BH, Setton J, Caria N, Romanyshyn J, Wolden SL, Zelefsky MJ, Park J, Rowan N, Sherman EJ, Fury MG, Ho A, Pfister DG, Wong RJ, Shah JP, Kraus DH, Zhang Z, Schupak KD, Gelblum DY, Rao SD, Lee NY
• Intensity-modulated radiotherapy in the treatment of oropharyngeal cancer: an update of the Memorial Sloan-Kettering Cancer Center experience.
  International journal of radiation oncology, biology, physics 2010 Setton J, Caria N, Romanyshyn J, Koutcher L, Wolden SL, Zelefsky MJ, Rowan N, Sherman EJ, Fury MG, Pfister DG, Wong RJ, Shah JP, Kraus DH, Shi W, Zhang Z, Schupak KD, Gelblum DY, Rao SD, Lee NY
• Long-term treatment of restless legs syndrome with dopamine agonists.
  Archives of neurology 2004 Ondo W, Romanyshyn J, Vuong KD, Lai D